PRJDX
Price
$46.90
Change
+$0.07 (+0.15%)
Updated
Aug 7 closing price
Net Assets
6.35B
RPEBX
Price
$68.50
Change
+$0.16 (+0.23%)
Updated
Aug 7 closing price
Net Assets
156.96B
Interact to see
Advertisement

PRJDX vs RPEBX

Header iconPRJDX vs RPEBX Comparison
Open Charts PRJDX vs RPEBXBanner chart's image
PGIM Jennison Global Opportunities R4
Price$46.90
Change+$0.07 (+0.15%)
VolumeN/A
Net Assets6.35B
American Funds New Perspective R2E
Price$68.50
Change+$0.16 (+0.23%)
VolumeN/A
Net Assets156.96B
PRJDX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PRJDX vs. RPEBX commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRJDX is a StrongBuy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 157B vs. PRJDX (6.35B). RPEBX pays higher dividends than PRJDX: RPEBX (0.12) vs PRJDX (0.00). PRJDX was incepted earlier than RPEBX: PRJDX (7 years) vs RPEBX (11 years). PRJDX (2.34) is less costly to investors than RPEBX (1.21). PRJDX is a more actively managed with annual turnover of: 66.00 vs. RPEBX (24.00). PRJDX has a lower initial minimum investment than RPEBX: PRJDX (0) vs RPEBX (250). RPEBX annual gain was more profitable for investors over the last year : 18.92 vs. PRJDX (9.31). RPEBX return over 5 years is better than : 34.73 vs. PRJDX (23.33).
PRJDXRPEBXPRJDX / RPEBX
Total Expense Ratio1.081.2189%
Annual Report Gross Expense Ratio2.341.21193%
Fund Existence7 years11 years-
Gain YTD3.17313.46724%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.35B157B4%
Annual Yield % from dividends0.000.12-
Returns for 1 year9.3118.9249%
Returns for 3 years47.1734.78136%
Returns for 5 years23.3334.7367%
Returns for 10 yearsN/A75.91-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS9.390.64
+7.31%
Viatris
VYNE0.380.01
+3.32%
VYNE Therapeutics
PLOW30.770.20
+0.65%
Douglas Dynamics
HLVX2.060.01
+0.49%
HilleVax
CVBF19.03-0.01
-0.05%
CVB Financial Corp